Tracking adverse events by just adjusting for age and sex, like the CDC did for myocarditis, is not enough. Proper analysis needs detailed individual-level data to predict event rates. This advanced statistical modeling reveals the true expected numbers, allowing for a more accurate comparison against observed events.